Insmed, Inc. (INSM)
118.07
-2.68
(-2.22%)
USD |
NASDAQ |
Nov 12, 16:00
118.49
+0.42
(+0.36%)
After-Hours: 20:00
Insmed Free Cash Flow (Quarterly) : -42.08M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -42.08M |
| June 30, 2026 | -95.09M |
| March 31, 2026 | -226.22M |
| December 31, 2025 | -294.18M |
| September 30, 2025 | -222.18M |
| June 30, 2025 | -209.05M |
| March 31, 2025 | -272.16M |
| December 31, 2024 | -202.75M |
| September 30, 2024 | -184.60M |
| June 30, 2024 | -129.74M |
| March 31, 2024 | -188.71M |
| December 31, 2023 | -131.75M |
| September 30, 2023 | -139.19M |
| June 30, 2023 | -127.68M |
| March 31, 2023 | -150.92M |
| December 31, 2022 | -107.84M |
| September 30, 2022 | -90.41M |
| June 30, 2022 | -105.20M |
| March 31, 2022 | -106.86M |
| December 31, 2021 | -85.27M |
| September 30, 2021 | -76.93M |
| June 30, 2021 | -78.93M |
| March 31, 2021 | -129.46M |
| December 31, 2020 | -67.72M |
| September 30, 2020 | -59.42M |
| Date | Value |
|---|---|
| June 30, 2020 | -37.83M |
| March 31, 2020 | -60.61M |
| December 31, 2019 | -57.44M |
| September 30, 2019 | -66.96M |
| June 30, 2019 | -90.64M |
| March 31, 2019 | -77.88M |
| December 31, 2018 | -72.56M |
| September 30, 2018 | -67.34M |
| June 30, 2018 | -57.76M |
| March 31, 2018 | -73.40M |
| December 31, 2017 | -49.92M |
| September 30, 2017 | -38.68M |
| June 30, 2017 | -36.68M |
| March 31, 2017 | -37.33M |
| December 31, 2016 | -58.73M |
| September 30, 2016 | -32.28M |
| June 30, 2016 | -29.78M |
| March 31, 2016 | -30.12M |
| December 31, 2015 | -27.95M |
| September 30, 2015 | -24.88M |
| June 30, 2015 | -25.17M |
| March 31, 2015 | -26.15M |
| December 31, 2014 | -14.47M |
| September 30, 2014 | -23.82M |
| June 30, 2014 | -18.49M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 271.15M |
| Gilead Sciences, Inc. | 4.798B |
| Incyte Corp. | -690.95M |
| Vertex Pharmaceuticals, Inc. | 545.80M |
| Regeneron Pharmaceuticals, Inc. | 1.427B |